Metastasis associated genomic aberrations in stage II rectal cancer

@article{Zhao2016MetastasisAG,
  title={Metastasis associated genomic aberrations in stage II rectal cancer},
  author={Hong Zhao and Zhi-Zhou Shi and Rui Jiang and Dong-Bing Zhao and Hai-tao Zhou and Jianwei Liang and Xin-yu Bi and Jian-jun Zhao and Zhi-yu Li and Jianguo Zhou and Zhen Huang and Ye-fan Zhang and Jian Wang and Xin Xu and Yan Cai and Ming-Rong Wang and Yu Alex Zhang},
  journal={Genes \& Genomics},
  year={2016},
  volume={38},
  pages={1085-1094}
}
Genomic aberrations of rectal carcinoma, especially DNA copy number changes associated with metastasis were largely unclear. We aim to identify the metastasis associated biomarkers in stage II rectal cancer. Formalin-fixed, paraffin-embedded primary tumor tissues of stage II rectal carcinoma were analyzed by array-based comparative genomic hybridization, and genomic aberrations were identified by Genomic Workbench and SAM software. Copy number changes and mRNA expressions were validated by Real… 
View on Springer
1 Citations

Figures and Tables from this paper

One Citation

Citation Type

Citation Type

Compositional and Functional Differences between Microbiota and Cervical Carcinogenesis as Identified by Shotgun Metagenomic Sequencing
TLDR
C cervical metagenomes were enriched in the course of peptidoglycan synthesis and depleted by dioxin degradation and 4-oxalocrotonate tautomerase, suggesting that cervical microbiome community compositions and their metagenomics profiles differed between cervical lesions and normal subjects.

References

SHOWING 1-10 OF 39 REFERENCES
DNA copy number aberrations associated with the clinicopathological features of colorectal cancers: Identification of genomic biomarkers by array-based comparative genomic hybridization.
TLDR
DNA copy number aberrations were identified in association with clinicopathological features of colorectal cancer and can be regarded as genomic biomarkers to predict the clinical outcome of patients with CRC, and are expected to serve to individualize the treatment of CRC patients.
Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors
TLDR
It is observed that crude aneuploidy and increased proliferative activity are early events in colorectal carcinogenesis, followed by TP53 overexpression and the acquisition of recurrent chromosomal gains and losses during the progression from high‐grade adenomas to invasive carcinomas.
Array Comparative Genomic Hybridization Analysis of Colorectal Cancer Cell Lines and Primary Carcinomas
TLDR
The overall pattern of copy number change was strikingly similar between cell lines and primary cancers with a few obvious exceptions such as loss of chromosome 6 and gain of chromosomes 15 and 12p in the former.
Specific genomic aberrations in primary colorectal cancer are associated with liver metastases
TLDR
Liver specific CRC metastases may be predicted with a high accuracy based on specific genomic aberrations in the primary CRC tumor.
Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression
TLDR
C20orf24, AURKA, RNPC1, TH1L, ADRM1, C20orf20 and TCFL5 genes are revealed to be important in chromosomal instability-related adenoma to carcinoma progression and may serve as highly specific biomarkers for colorectal cancer with potential clinical applications.
A Genome-Wide Study of Cytogenetic Changes in Colorectal Cancer Using SNP Microarrays: Opportunities for Future Personalized Treatment
TLDR
This study shows the application of high density SNP arrays for cytogenetic study in CRC and its potential utility for personalized treatment, and identified relevant drugs, targeted to the genes located in these regions with CN changes, approved or in trials for other cancers and common diseases.
High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization.
TLDR
This high-resolution analysis of DNA copy number alterations in colorectal cancer by array-based CGH allowed for the identification of many small, previously uncharacterized, genomic regions, such as on chromosomes 8 and 20.
Impact of chromosomal instability on colorectal cancer progression and outcome
TLDR
The data show that CRC disease progression from stage 1 to stage 4 is not paralleled by increased levels of genetic instability, but they suggest that stage 2–3 CRC with elevated genetic instability and particularly profiles with fractional CNA represent a subset of aggressive tumors.
Chromosome 20p11 gains are associated with liver-specific metastasis in patients with colorectal cancer
TLDR
C20orf3 mapping at 20p11 is associated with hepatic-specific metastasis in patients with CRC and is a candidate biomarker for liver metastases and may be of clinical value in early-stage CRC.
Genome-wide DNA Copy-number Analysis in ACTS-CC Trial of Adjuvant Chemotherapy for Stage III Colonic Cancer.
TLDR
Somatic copy-number alteration profiles of stage III colonic cancer in the Japanese ACTS-CC trial closely agreed with the results of previous Western studies, and will facilitate understanding the characteristics of Colonic cancer.
...
1
2
3
4
...